BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23432688)

  • 1. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
    Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
    Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
    Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
    Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
    Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
    Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
    Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
    Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
    Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
    Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
    Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
    J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
    Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
    Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
    Guo B; Cen H; Tan X; Ke Q
    BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.
    Koh YW; Park CS; Yoon DH; Suh C; Huh J
    PLoS One; 2014; 9(1):e87066. PubMed ID: 24489836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
    Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
    Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
    Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
    Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
    Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
    Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
    Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
    Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
    Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
    Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.
    Deau B; Bachy E; Ribrag V; Delarue R; Rubio MT; Bosq J; Varet B; Brousse N; Hermine O; Canioni D
    Leuk Lymphoma; 2013 Jan; 54(1):41-5. PubMed ID: 22667341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome.
    Werner L; Dreyer JH; Hartmann D; Barros MHM; Büttner-Herold M; Grittner U; Niedobitek G
    Sci Rep; 2020 Jun; 10(1):9410. PubMed ID: 32523087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.